Skip to content

Improving the Pregnancy Rate With Endometrial Sampling Before Intrauterine Insemination

Improving the Pregnancy Rate With Endometrial Sampling Before Intrauterine Insemination

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00737984
Enrollment
9
Registered
2008-08-20
Start date
2008-08-31
Completion date
2011-08-31
Last updated
2012-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Pregnancy Rate, Infertility

Keywords

Infertility, Clinical pregnancy rate

Brief summary

Endometrial sampling improves the pregnancy rates in superovulation-IUI cycles

Detailed description

Endometrial sampling is performed using the standard technique in the outpatient department. Similarly, superovulation with gonadotrophins will be performed according to our standard practice.Endometrial sampling will be done in the follicular phase not later than day 10 of the cycle. Endometrial sampling will be performed using Pipelle sampling catheter. The Pipelle is inserted gently through the cervical canal into the uterine cavity and advanced slowly till just resistance felt by the operator. Then, the piston is withdrawn to create negative suction and gentle movement of Pipelle up and down in the uterine cavity is performed while it is against the uterine wall. The Pipelle catheter is withdrawn gently and any obtained specimen will be sent for histopathological examination.

Interventions

Endometrial sampling performed in the preceding cycle. It will be done in the follicular phase not later than day 10 of the cycle

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

1. All women undergoing superovulation with gonadotrophins and intrauterine insemination. 2. All women with cervical factor, mild male factor and/or unexplained infertility. 3. At least one patent Fallopian tube.

Exclusion criteria

1. Bilateral tubal disease 2. Severe male factor infertility 3. Intrauterine pathology (submucosal fibroid, endometrial polyp, adhesions) 4. Women with positive cervical culture and/or acute vaginal infection

Design outcomes

Primary

MeasureTime frame
The rate of clinical pregnancy24 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026